XEN1101 Demonstrates Significant Seizure Reduction in Patients with Refractory Focal Epilepsy, Offering New Hope for Treatment
A groundbreaking clinical trial has revealed that XEN1101, a novel medication, can significantly reduce seizure frequency in individuals with focal...
September 6, 2025